Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Zolinza vorinostat: Phase I data

In a Phase I trial in 23 evaluable patients, Zolinza plus Velcade bortezomib produced a partial

Read the full 169 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE